教員・教室員について

  1. TOP
  2. 教員・教室員について
  3. 教員・教室員紹介
  4. 教員
  5. 第一内科
  6. 江里口 芳裕（えりぐち よしひろ）

助教

名前 江里口 芳裕（えりぐち よしひろ）
卒業年 2001（平成13）年
学位取得年月 2012年9月　医学博士学位取得
専門領域 感染症学、消化器病学、救急医学、免疫学
資格 日本内科学会認定内科医・総合内科専門医、日本感染症学会指導医、抗菌化学療法指導医、インフェクションコントロール・ドクター、日本消化器病学会専門医、日本消化器内視鏡学会専門医、日本救急医学会救急科専門医
所属学会 日本内科学会、日本感染症学会、日本化学療法学会、日本消化器病学会、日本消化器内視鏡学会、日本救急医学会

略歴

2001-2003

 国家公務員共済組合連合会浜の町病院、九州大学病院、宗像医師会病院 研修医

2003-2005

 佐賀大学医学部附属病院 消化器内科 医員

2005-2009

 九州大学病態修復内科学

2009-2011

 九州大学病院 救命救急センター 医員
2011 九州大学大学院医学研究院 先端医療医学部門 先端医療医学講座 助教
2012 九州大学病院 救命救急センター 助教
2013 Keck School of Medicine of USC, Department of Pathology & Laboratory Medicine, Visiting Research Scholar
2014-2017 同上　Postdoctoral Scholar Research Associate
2018 同上　Research Associate
2019 九州大学病院 免疫・膠原病・感染症内科 助教

代表的業績

​Yoshihiro Eriguchi – 研究成果 — 九州大学 (elsevierpure.com)

  1. Fujimoto S, et al. Streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis from retroperitoneal panniculitis during the treatment with anti-IL-6 receptor antibody: A case report. Mod Rheumatol Case Rep. 2024; Epub ahead of print. PMID: 38217091.
  2. Nishida R, et al. Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009-2020. Med Mycol. 2023 Jun 5;61:myad056.
  3. Tanimoto T, et al. Platypnea-Orthodeoxia Syndrome in Coronavirus Disease 2019 Pneumonia: A Case Report and Literature Review. Int Med Case Rep J. 2023;16:201-207.
  4. Edahiro R, et al. Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity. Nat Genet. 2023;55:753-767.
  5. Namkoong H, et al. DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature. 2022;609:754-760. 
  6. Wang QS, et al. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force. Nat Commun. 2022;13:4830.
  7. Schaal JB, et al. A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections. Sci Rep. 2021;11:23447.
  8. COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600:472-477.
  9. Lai KKY, et al. p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and Repair. Cancers (Basel). 2021;13:1288.
  10. Skrypek K, et al. Inhibition of Stearoyl-CoA Desaturase Induces the Unfolded Protein Response in Pancreatic Tumors and Suppresses Their Growth. Pancreas. 2021; 50: 219-226.
  11. Chong Y, et al. Clinical significance of SARS‐CoV‐2‐specific IgG detection with a rapid antibody kit for COVID‐19 patients. Influenza Other Respir Viruses. 2021; 15: 13–18.
  12. Basso V, et al. Rhesus Theta Defensin 1 Promotes Long Term Survival in Systemic Candidiasis by Host Directed Mechanisms. Sci Rep. 2019; 9: 16905.
  13. Eriguchi Y, et al. Essential role of IFN-gamma in T cell-associated intestinal inflammation. JCI Insight. 2018; 3(18). 
  14. Cobo ER, et al, Entamoeba histolytica Alters Ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency. Infect Immun. 2018; 86(10). 
  15. Eriguchi Y, et al. Decreased secretion of Paneth cell alpha-defensins in graft-versus-host disease. Transpl Infect Dis. 2015; 17: 702-706.
  16. Eriguchi Y, et al. Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2013; 19: 1525-1529. 
  17. Shimoji S, et al. Evaluating the association between histological manifestations of cord colitis syndrome with GVHD. Bone Marrow Transplant. 2013; 48: 1249-1252. 
  18. Eriguchi Y, et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of a-defensins. Blood. 2012; 120: 223-231.
  19. Miyake N, et al. Influence of inoculum size on MICs for methicillin-susceptible Stapylococcus aureus and methicillin-resistant Staphylococcus aureus. Jpn J Antibiot. 2011; 64: 231-237. 
  20. Uchida Y, et al. Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors. Int J Antimicrob Agents. 2010; 35: 444-450.
  21. Maehara Y, et al. Hematological unit invasive aspergillosis epidemiology. Kanshogaku Zasshi. 2010; 84: 176-181.
  22. Nagasaki Y, et al. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model. J Antimicrob Chemother 2009; 64: 379-382.
  23. Kuwayama H, et al. Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan. Aliment Pharmacol Ther. 2007; 25: 1105-1113.
  24. Eriguchi Y, et al. A case of relapsed ischemic colitis with colon cast-like stripped mucosa. Nihon Shokakibyo Gakkai Zasshi. 2006; 103: 1152-1156.

一覧